Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

KOGNITIVE BEWERTUNG UND POSTOPERATIVE KOMPLIKATIONEN NACH EINER OPERATION: VERBINDUNG VON ANÄSTHESIE UND RISIKO (CAPSULAR)

21. September 2026 aktualisiert von: University of Edinburgh

Many older people can experience confusion, memory problems, or a decline in their thinking after major surgery. These problems are sometimes called 'postoperative neurocognitive disorders' or PND and can affect recovery and a person's ability to live independently.

The investigators want to find out the best way to study these problems in older patients undergoing surgery. This is a 'feasibility study', which means we are testing the research methods. The investigators want to see if it is possible to ask participants to do memory tests and give blood samples before and after their operation. The investigators are hoping to include around 40 patients over 2 years in this study.

The investigators will compare performance in memory (cognitive assessment) findings before and after surgery and link this to data taken from the anaesthetic, including the types of drugs used, duration, brain features from processed electroencephalogram monitoring and standard recommended monitoring. In addition the investigators will link this to blood sample markers of brain health and function (biomarkers).

The results of this study will help the investigators plan a much larger study in the future, with the ultimate goal of making surgery safer for the brain.

Studienübersicht

Detaillierte Beschreibung

SUMMARY

Older patients can experience significant difficulties with memory and thinking (known as cognitive problems) after major surgery. The specific reasons in this vulnerable group are not yet clearly understood.

CAPSULAR is a single-centre feasibility research project at the Western General Hospital, Edinburgh, that aims to find the best way to conduct detailed research into this problem.

Objectives:

Main Aim:

- To determine if it is practical and feasible to screen older participants (age ≥ 70) for cognitive problems both before surgery and up to 7 days after surgery (or before leaving hospital, if earlier).

Secondary Aims:

  • Collect extra blood samples (at the same time as routine clinical blood tests) to measure markers of potential brain injury. These will be collected before, immediately after, and up to 7 days after surgery (or before leaving hospital, if earlier).
  • Gather detailed data on the participant's health, frailty, and the anaesthetic technique used, including standard brain monitoring (pEEG) to monitor anaesthesia depth during the operation.
  • Look for a link between anaesthesia technique and the risk of cognitive problems and blood markers of brain injury.
  • Proxy outcomes to inform economic analysis in a larger planned trial e.g. impact on changes in care need, cognitive aids such as new use of a multi-compartment drug compliance aid.

We plan to recruit 40 patients aged ≥ 70 who are scheduled for colorectal or urological surgery lasting over one hour. Participants will be those already attending the POPS (Perioperative Medicine for Older People undergoing Surgery) clinic.

The study will measure success based on the percentage of eligible patients who agree to take part, complete the one-week cognitive screening, and provide all the necessary blood and data samples.

This research will provide the crucial initial evidence needed to plan future definitive trials exploring whether altering anaesthetic or surgical care can safely reduce brain problems for older and frailer patients.

2 INTRODUCTION

2.1 BACKGROUND

Postoperative neurocognitive disorders (PND) represent a spectrum of cognitive impairments that can arise after surgery, ranging from acute, reversible, postoperative delirium to more persistent, and sometimes subtle, cognitive decline. These disorders are particularly common in older adults, with reported incidence rates for postoperative delirium as high as 40% following major elective surgery. The consequences are significant, including prolonged hospital stays, increased patient morbidity and mortality, and a greater likelihood of long-term cognitive impairment, which can profoundly reduce a patient's quality of life and independence. Additionally, there may be further impact economically and upon the formal and informal care sectors for example new dependence on aids.

The investigators' previous work with the Perioperative Care for Older People Undergoing Surgery (POPS) Clinic at the Western General Hospital, Edinburgh, identified that 21% of patients scheduled for major surgery had previously unrecognised pre-operative cognitive impairment. This cohort subsequently experienced a high incidence of PND, particularly delirium, affecting 40% of those who underwent emergency surgery and 5% of those undergoing elective surgery. This highlights a vulnerable patient population in whom the risks of postoperative cognitive decline are substantial.

The pathophysiology of PND is thought to be multifactorial, involving interplay between patient-specific risk factors (e.g., advanced age, frailty, pre-existing cognitive deficits) and procedural factors, such as surgical stress, systemic inflammation, and anaesthetic technique. Previous research has often included younger and less frail individuals, leaving a critical knowledge gap concerning those elderly and frailer patients who are possibly most at risk.

Given the increasing trend towards older patients undergoing major surgery, there is therefore, an urgent need for research focused specifically on elderly and frail patients to identify reliable risk factors. This includes physiological and molecular biomarkers predictive of PND. This knowledge will enable us to better identify at-risk patients to inform consent, guide preventative resources, and stratify participants for future trials of therapeutic interventions.

2.2 RATIONALE FOR STUDY

One near-universal criticism of the existing literature in this area has been that study cohorts have not been of a sufficiently advanced age. The investigators' research location hospital and clinic stream enables them to set recruitment at 70 years of age or over, as one in five, over-75 year olds, are predicted to undergo surgery from 2030.

While the pilot data established a high incidence of PND in a high-risk cohort, the investigators now need to investigate and categorise the nature of PND with greater accuracy and determine if it is feasible to robustly investigate the impact of perioperative factors on cognitive outcomes.

This project aims to address this evidence gap. The investigators will conduct a prospective feasibility study to establish the practicalities of performing detailed, domain-specific cognitive testing in a high-risk, frail, older patient population at baseline (preoperatively) and postoperatively. This will allow them to accurately quantify the incidence of new or worsening cognitive impairment following major surgery. Furthermore, the investigators will assess the feasibility of systematically collecting detailed data on anaesthetic technique, including intra-operative processed EEG metrics, and obtaining serial blood samples for biomarker analysis. Finally the investigators will assess proxy- patient impact and economic markers such as predicted vs. actual length of stay, change to living arrangements and provision of new aids.

The investigators hypothesize that it is feasible to recruit this cohort and perform these detailed assessments. This work is critical as it will provide the foundational data necessary to design a larger, adequately powered trial to determine whether specific anaesthetic practices, such as pEEG-guided anaesthesia to minimise burst suppression, can mitigate the risk of long-lasting postoperative cognitive decline in vulnerable patients. It will inform the design of research aimed at generating data to help identify at-risk patients, possibly identify modifiable factors and quantify the incidence which would help improve the accuracy of pre-surgery counselling.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

40

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Kieran P Nunn, MB BS, BSc(h), FRCA, FFICM
  • Telefonnummer: +441315371652
  • E-Mail: kieran.nunn@nhs.scot

Studieren Sie die Kontaktsicherung

  • Name: Zoeb Jiwaji, MBBCh, PhD, MRCP, FRCA, FFICM
  • Telefonnummer: +441315371652
  • E-Mail: zoeb.jiwaji@ed.ac.uk

Studienorte

    • Midlothian
      • Edinburgh, Midlothian, Vereinigtes Königreich, EH4 2XU
        • Western General Hospital
        • Kontakt:
          • Kieran P Nunn, MBBS, BSc (hons), FRCA, FFICM
          • Telefonnummer: +441315371652
          • E-Mail: kieran.nunn@nhs.scot
        • Kontakt:
        • Unterermittler:
          • Helen Jones, MBChB

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

70 Jahre und älter (Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Wahrscheinlichkeitsstichprobe

Studienpopulation

We will conduct a prospective, single-centre feasibility cohort study over a period of 24 months, recruiting patients from the Perioperative medicine for Older People having Surgery clinic (POPS) clinic at the Western General Hospital, Edinburgh, who are scheduled for major surgery. This is a pre-surgery clinic and physician-led inpatient follow up service with discharge planning roles. Note, the nature of the clinical pathway means that patients may wait several months from POPS clinic review until surgery.

Beschreibung

Inclusion Criteria:

  • Age ≥ 70
  • Seen in the Perioperative medicine for Older People undergoing Surgery (POPS) clinic
  • Scheduled for colorectal or urological surgery with expected anaesthesia time over 60 minutes

Exclusion Criteria:

  • Regional anaesthesia only
  • Planned day surgery or expected hospital stay < 24 hours
  • Expected to remain sedated and ventilated for > 24 hours postoperatively
  • Participant does not wish to remain in the study if capacity is lost during the study

CO-ENROLMENT

  • As this is a non-intervention study, co-enrolment will be permitted in other studies that do not conflict with this protocol.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: COHORT
  • Zeitperspektiven: PROSPECTIVE

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Perioperative medicine for Older People undergoing Surgery (POPS) clinic patients

Age > 70, scheduled for colorectal or urological surgery with expected anaesthesia time over 60 minutes.

Preoperative and Postoperative MoCA

  • Pre-operatively: sample collected at a suitable time of blood draw for routine peri-operative clinical samples or insertion of a peripheral venous cannula as part of routine anaesthetic care after consent and enrollment. This may be in the POPS clinic or on day of admission for surgery or when canulated for anaesthesia.
  • Immediate post-operative period: sample collected in recovery or on the ward at the first ordered routine blood-draw.
  • Up to 7 days post-surgery: sample collected on the ward (or last anticipated routine sample).

Biomarkers assessed will be a panel linked to brain injury, inflammation, and cognitive impairment in non-ICU populations.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
The proportion of eligible patients who consent to participate and are successfully screened for delayed neurocognitive recovery up to discharge or 7 days, whichever is sooner.
Zeitfenster: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

The overall aim is to test the feasibility of this research being conducted on a larger scale. The primary outcome assesses the proportion of eligible patients who consent and then undergo pre- and post-operative cognitive testing.

Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
The proportion of consented patients from whom a complete set of blood samples (pre-anaesthesia, post-anaesthesia, and up to discharge or 7 days, whichever is sooner) is successfully collected and stored.
Zeitfenster: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

The overall aim is to test the feasibility of this research being conducted on a larger scale. The outcome assesses the proportion of eligible patients who consent and then provide pre-, immediately-post-operative and pre-discharge biomarker blood samples (additional tubes/samples from routine blood-lets).

Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).
The proportion of consented patients for whom complete anaesthetic data, including depth of anaesthesia parameters, are successfully retrieved from electronic records.
Zeitfenster: The time-gap between clinic and surgery depends upon many factors, as does post-operative duration. Participants will be involved within the study from time of consent until up to 7-days after surgery or to hospital discharge (whichever is sooner).

The overall aim is to test the feasibility of this research being conducted on a larger scale. The outcome assesses the proportion of eligible patients who consent and then have a complete intraoperative data-set collected.

The time-gap between clinic and surgery depends upon many factors, as does post-operative duration. Participants will be involved within the study from time of consent until up to 7-days after surgery or to hospital discharge (whichever is sooner).
The incidence and nature of PND identified through domain-specific cognitive testing.
Zeitfenster: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Analysis of the performance in the Montreal Cognitive Assessment (MoCA) tool allows us to both analyse incidence, but also features of, any identified cognitive changes across the timespan of the patients preparation and undertaking of surgery.

Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
New functional dependence at hospital discharge as identified by change in home social support or requirement for aids (e.g. Dossette box).
Zeitfenster: Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

New support for independent living or new dependence will be recorded at the point the patient leaves the study in order to better understand this and plan for the economic impact analysis in a future study.

Participants will be involved within the study from time of consent (expected at their POPS clinic visit) until up to 7-days after surgery or to hospital discharge (whichever is sooner).

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Mitarbeiter

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. November 2026

Primärer Abschluss (Geschätzt)

1. März 2028

Studienabschluss (Geschätzt)

1. März 2028

Studienanmeldedaten

Zuerst eingereicht

10. März 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

10. März 2026

Zuerst gepostet (Tatsächlich)

13. März 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

24. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

21. September 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren